Novel pharmacotherapeutic avenues for bladder storage dysfunction in men

Area of Science:

• Urology
• Pharmacology
• Medical Research

Background:

• Bladder storage dysfunction significantly impacts men's quality of life.
• Current pharmacotherapies exhibit insufficient efficacy and adverse effects, leading to low patient persistence.
• There is a critical need for novel treatment strategies due to the limitations of existing therapies.

Purpose of the Study:

• To review the pathophysiology of male bladder storage dysfunction.
• To summarize current pharmacotherapeutic approaches.
• To explore emerging novel drugs and molecular targets in ongoing clinical trials.

Main Methods:

• Literature review of pathophysiology and current treatments.
• Analysis of emerging pharmacotherapies targeting novel molecular pathways.
• Evaluation of research focusing on clinical trials for new drugs.

Main Results:

• Existing treatments targeting alpha-adrenergic, beta-adrenergic, and muscarinic receptors show limitations.
• Numerous alternative molecular targets regulating bladder afferent nerve activity have been identified.
• Limited clinical trials exist for novel pharmacotherapies, with no clear superiority demonstrated yet.

Conclusions:

• Further research is essential to develop effective pharmacotherapies for male bladder storage dysfunction.
• Novel molecular targets show promise but require extensive clinical evaluation.
• Addressing limitations in efficacy and side effects is crucial for improving patient persistence and quality of life.